MD
Mazzo David J
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Mazzo David J, 董事长兼首席执行官. Director active across 2 companies, notably Caladrius Biosciences, INC.. Cumulatively, 13 filings have been recorded. Activity tracked since 10 January 2022. The latest transaction was disclosed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mazzo David J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
81,000 股0Common StockSEC:0001334549-26-000003:0
81,000 股0Common StockSEC:0001334549-25-000002:0
58,000 股@ US$2.9395.5% 占其流量Common StockSEC:0001334549-24-000006:0
1,026 股@ US$2.991.7% 占其流量Common StockSEC:0001334549-24-000004:0
94,000 股0Common StockSEC:0001334549-24-000002:0
397 股@ US$3.650.8% 占其流量Common StockSEC:0001334549-23-000006:0
1,030 股@ US$3.201.9% 占其流量Common StockSEC:0001334549-23-000004:0
60,000 股0Common StockSEC:0001334549-23-000002:0
150,000 股@ US$0.5089.2% 占其流量Common StockSEC:0001334549-22-000007:0
6,471 股@ US$0.80635.7% 占其流量Common StockSEC:0001334549-22-000004:0
401,000 股0Common StockSEC:0001334549-22-000002:0
212,800 股Common StockSEC:0001144204-16-077388:0
21,094 股Common StockSEC:0001144204-16-077388:1
About Mazzo David J
Mazzo David J is President & CEO. He has 13 filings in total. Among the sampled recent filings, the prevailing transaction nature is Attribution, with buy and sell amounts of EUR 0 each, over the period from 2016-01-27 to 2026-01-13.